Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals
Status:
Recruiting
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the ability of Doravirine to penetrate the genital tract and
suppress viral replication and provide evidence for the use of Doravirine as part of
treatment strategies as prevention.
Phase:
Phase 2
Details
Lead Sponsor:
Fundacio Lluita Contra la SIDA Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Collaborators:
Hospital Universitari de Bellvitge Institut d'Investigació Biomèdica de Bellvitge